Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
DIAMOX Tablets are for oral administration. Acteazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. It is indicated in the treatment of:
Adults: 250-1,000mg (1-4 tablets) per 24 hours, usually in divided doses for amounts over 250mg daily.
Adults: For diuresis, the starting dose is usually 250-375mg (1-1½ tablets) once daily in the morning. If, after an initial response, the patient fails to continue to lose oedema fluid, do not increase the dose but allow for kidney recovery by omitting a day. Best results are often obtained on a regime of 250-375mg (1-1½ tablets) daily for two days, rest a day, and repeat, or merely giving the DIAMOX tablets every other day. The use of DIAMOX tablets does not eliminate the need for other therapy, eg. digitalis, bed rest and salt restriction in congestive heart failure and proper supplementation with elements such as potassium in drug-induced oedema.
For cases of fluid retention associated with pre-menstrual tension, a daily dose (single) of 125-375mg is suggested.
Adults: 250-1,000mg daily in divided doses.
Children: 8-30mg/kg in daily divided doses and not to exceed 750mg/day. The change from other medication to DIAMOX tablets should be gradual.
Elderly: DIAMOX tablets should only be used with particular caution in elderly patients or those with potential obstruction in the urinary tract or with disorders rendering their electrolyte balance precarious or with liver dysfunction.
No specific antidote. Supportive measures with correction of electrolyte and fluid balance. Force fluids.
48 months.
Do not store above 25°C. Store in the original pack in order to protect from light and moisture.
Amber glass bottles with metal screw-on caps.
Polypropylene bottles with plastic screw-on caps.
The product is supplied in bottles of 112 tablets.
None.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.